Moreover, Tf-CT-MEs also reduced the serum concentrations of inflammatory factors (TGF-β1, CCL2, TNF-α, and IL-6), and Tf-CT-MEs enhanced tumor targeting, promoted the deep penetration of drug components, and improved the treatment of cervical cancer (100). The gene discussed is TF; the disease is neoplasm.